243 related articles for article (PubMed ID: 16618869)
1. Recent tanning bed use: a risk factor for melanoma.
Buckel TB; Goldstein AM; Fraser MC; Rogers B; Tucker MA
Arch Dermatol; 2006 Apr; 142(4):485-8. PubMed ID: 16618869
[TBL] [Abstract][Full Text] [Related]
2. Tanning bed exposure increases the risk of malignant melanoma.
Ting W; Schultz K; Cac NN; Peterson M; Walling HW
Int J Dermatol; 2007 Dec; 46(12):1253-7. PubMed ID: 18173518
[TBL] [Abstract][Full Text] [Related]
3. Sun protection practices among offspring of women with personal or family history of skin cancer.
Geller AC; Brooks DR; Colditz GA; Koh HK; Frazier AL
Pediatrics; 2006 Apr; 117(4):e688-94. PubMed ID: 16585282
[TBL] [Abstract][Full Text] [Related]
4. Another duel in the sun: weighing the balances between sun protection, tanning beds, and malignant melanoma.
Roberts DJ; Hornung CA; Polk HC
Clin Pediatr (Phila); 2009 Jul; 48(6):614-22. PubMed ID: 19286623
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic carcinoma surveillance in patients with familial melanoma.
Parker JF; Florell SR; Alexander A; DiSario JA; Shami PJ; Leachman SA
Arch Dermatol; 2003 Aug; 139(8):1019-25. PubMed ID: 12925390
[TBL] [Abstract][Full Text] [Related]
6. Test-retest of self-reported exposure to artificial tanning devices, self-tanning creams, and sun sensitivity showed consistency.
Beane Freeman LE; Dennis LK; Lynch CF; Lowe JB; Clarke WR
J Clin Epidemiol; 2005 Apr; 58(4):430-2. PubMed ID: 15862730
[TBL] [Abstract][Full Text] [Related]
7. Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.
Figl A; Thirumaran RK; Ugurel S; Gast A; Hemminki K; Kumar R; Schadendorf D
Arch Dermatol; 2007 Apr; 143(4):495-9. PubMed ID: 17438182
[TBL] [Abstract][Full Text] [Related]
8. [Risk factors for the development of malignant melanomas].
Itin PH
Ther Umsch; 1999 Jun; 56(6):298-301. PubMed ID: 10420810
[TBL] [Abstract][Full Text] [Related]
9. Molecular and genetic mechanisms in melanoma.
Gruber F; Kastelan M; Brajac I; Saftić M; Peharda V; Cabrijan L; Stanić Zgombić Z; Simonić E
Coll Antropol; 2008 Oct; 32 Suppl 2():147-52. PubMed ID: 19138018
[TBL] [Abstract][Full Text] [Related]
10. First detection of the melanoma-predisposing proline-48-threonine mutation of p16 in Hungarians: was there a common founder either in Italy or in Hungary?
Széll M; Balogh K; Dobozy A; Kemény L; Oláh J
Melanoma Res; 2007 Aug; 17(4):251-4. PubMed ID: 17625456
[TBL] [Abstract][Full Text] [Related]
11. Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation.
Eliason MJ; Hansen CB; Hart M; Porter-Gill P; Chen W; Sturm RA; Bowen G; Florell SR; Harris RM; Cannon-Albright LA; Swinyer L; Leachman SA
Arch Dermatol; 2007 Nov; 143(11):1409-12. PubMed ID: 18025365
[TBL] [Abstract][Full Text] [Related]
12. Indoor tanning is strongly linked to melanoma risk.
Harv Womens Health Watch; 2010 Sep; 18(1):7. PubMed ID: 20960704
[No Abstract] [Full Text] [Related]
13. Impaired processing of DNA photoproducts and ultraviolet hypermutability with loss of p16INK4a or p19ARF.
Sarkar-Agrawal P; Vergilis I; Sharpless NE; DePinho RA; Rünger TM
J Natl Cancer Inst; 2004 Dec; 96(23):1790-3. PubMed ID: 15572761
[TBL] [Abstract][Full Text] [Related]
14. CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families.
Aspinwall LG; Leaf SL; Dola ER; Kohlmann W; Leachman SA
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1510-9. PubMed ID: 18559569
[TBL] [Abstract][Full Text] [Related]
15. Indoor tanning and risk of melanoma: a case-control study in a highly exposed population - letter.
Grant WB; Pope SJ; Moan JE
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2685; author reply 2685-6. PubMed ID: 20929885
[No Abstract] [Full Text] [Related]
16. Impact of Sun Exposure and Tanning Patterns on Next-Generation Sequencing Mutations in Melanoma.
Loo K; Soliman I; Renzetti M; Li T; Wu H; Reddy S; Olszanski AJ; Farma JM
J Surg Res; 2020 Oct; 254():147-153. PubMed ID: 32445930
[TBL] [Abstract][Full Text] [Related]
17. Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients.
Council ML; Gardner JM; Helms C; Liu Y; Cornelius LA; Bowcock AM
Exp Dermatol; 2009 May; 18(5):485-7. PubMed ID: 19320745
[TBL] [Abstract][Full Text] [Related]
18. [Can the risk of melanoma be calculated?].
Jung EG
Z Hautkr; 1988 Jul; 63(7):559-62. PubMed ID: 3055724
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.
Berwick M; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Kanetsky PA; Busam K; From L; Mujumdar U; Wilcox H; Begg CB;
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1520-5. PubMed ID: 16896043
[TBL] [Abstract][Full Text] [Related]
20. CDKN2A/CDK4 molecular study on 155 Italian subjects with familial and/or primary multiple melanoma.
Majore S; De Simone P; Crisi A; Eibenschutz L; Binni F; Antigoni I; De Bernardo C; Catricalà C; Grammatico P
Pigment Cell Melanoma Res; 2008 Apr; 21(2):209-11. PubMed ID: 18363633
[No Abstract] [Full Text] [Related]
[Next] [New Search]
